KEGG   PATHWAY: bta05202
Entry
bta05202                    Pathway                                
Name
Transcriptional misregulation in cancer - Bos taurus (cow)
Description
In tumor cells, genes encoding transcription factors (TFs) are often amplified, deleted, rearranged via chromosomal translocation and inversion, or subjected to point mutations that result in a gain- or loss-of- function. In hematopoietic cancers and solid tumors, the translocations and inversions increase or deregulate transcription of the oncogene. Recurrent chromosome translocations generate novel fusion oncoproteins, which are common in myeloid cancers and soft-tissue sarcomas. The fusion proteins have aberrant transcriptional function compared to their wild-type counterparts. These fusion transcription factors alter expression of target genes, and thereby result in a variety of altered cellular properties that contribute to the tumourigenic process.
Class
Human Diseases; Cancer: overview
Pathway map
bta05202  Transcriptional misregulation in cancer
bta05202

Organism
Bos taurus (cow) [GN:bta]
Gene
100126050  ELANE; neutrophil elastase precursor [KO:K01327] [EC:3.4.21.37]
100138545  PML; protein PML [KO:K10054] [EC:2.3.2.-]
100297155  HMGA2; high mobility group protein HMGI-C [KO:K09283]
100297725  [KO:K11253]
100300510  [KO:K10785]
100300716  [KO:K06856]
100300806  [KO:K06856]
100300850  [KO:K10784]
100336578  HOXA11; homeobox protein Hox-A11 [KO:K21951]
100847469  [KO:K15624]
100847490  [KO:K11253]
101905053  [KO:K16060]
104968484  [KO:K06856]
104968644  IL2RB; interleukin-2 receptor subunit beta [KO:K05069]
107131750  [KO:K11253]
115945165  [KO:K11253]
115945167  H3C6; H3 clustered histone 6 [KO:K11253]
115945169  H3C8; H3 clustered histone 8 [KO:K11253]
115945171  [KO:K11253]
115945173  [KO:K11253]
132342081  BAIAP3; BAI1-associated protein 3 isoform X1 [KO:K15621]
132344466  [KO:K11447] [EC:1.14.11.68]
280730  BAX; apoptosis regulator BAX [KO:K02159]
280796  FUS; RNA-binding protein FUS [KO:K13098]
280823  IL3; interleukin-3 precursor [KO:K04736]
280826  IL6; interleukin-6 precursor [KO:K05405]
280828  CXCL8; interleukin-8 precursor [KO:K10030]
280855  MET; hepatocyte growth factor receptor precursor [KO:K05099] [EC:2.7.10.1]
280952  KDM6A; lysine-specific demethylase 6A [KO:K11447] [EC:1.14.11.68]
281048  CD14; monocyte differentiation antigen CD14 precursor [KO:K04391]
281095  CSF2; granulocyte-macrophage colony-stimulating factor precursor [KO:K05427]
281177  FUT8; alpha-(1,6)-fucosyltransferase [KO:K00717] [EC:2.4.1.68]
281239  IGF1; insulin-like growth factor I preproprotein [KO:K05459]
281309  MMP3; stromelysin-1 precursor [KO:K01394] [EC:3.4.24.17]
281407  PLAT; tissue-type plasminogen activator precursor [KO:K01343] [EC:3.4.21.68]
281408  PLAU; urokinase-type plasminogen activator precursor [KO:K01348] [EC:3.4.21.73]
281542  TP53; cellular tumor antigen p53 [KO:K04451]
281667  CCNA2; cyclin-A2 [KO:K06627]
281677  CEBPA; CCAAT/enhancer-binding protein alpha [KO:K09055]
281731  GZMB; duodenase-1 precursor [KO:K01353] [EC:3.4.21.79]
281848  IGF1R; insulin-like growth factor 1 receptor precursor [KO:K05087] [EC:2.7.10.1]
281993  PPARG; peroxisome proliferator-activated receptor gamma [KO:K08530]
282151  BCL2A1; bcl-2-related protein A1 [KO:K02162]
282152  BCL2L1; bcl-2-like protein 1 [KO:K04570]
282227  FCGR1A; high affinity immunoglobulin gamma Fc receptor I precursor [KO:K06498]
282261  IGFBP3; insulin-like growth factor-binding protein 3 precursor [KO:K10138]
282713  NFKBIZ; NF-kappa-B inhibitor zeta [KO:K14242]
282871  MMP9; matrix metalloproteinase-9 precursor [KO:K01403] [EC:3.4.24.35]
286849  CD40; tumor necrosis factor receptor superfamily member 5 precursor [KO:K03160]
326601  H3-3A; histone H3.3 [KO:K11253]
338319  CEBPB; CCAAT/enhancer-binding protein beta [KO:K10048]
353110  NGFR; tumor necrosis factor receptor superfamily member 16 precursor [KO:K02583]
353111  NTRK1; high affinity nerve growth factor receptor isoform X1 [KO:K03176] [EC:2.7.10.1]
404126  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
407124  ITGAM; integrin alpha-M precursor [KO:K06461]
407194  CCNT1; cyclin-T1 [KO:K15188]
407219  MITF; microphthalmia-associated transcription factor isoform M- [KO:K09455]
407223  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
414345  CD86; T-lymphocyte activation antigen CD86 [KO:K05413]
445543  JUP; junction plakoglobin [KO:K10056]
503620  FLT1; vascular endothelial growth factor receptor 1 precursor [KO:K05096] [EC:2.7.10.1]
504458  MLLT1; protein ENL isoform X1 [KO:K15187]
504512  ETV6; transcription factor ETV6 [KO:K03211]
504599  H3C13; histone H3.2 [KO:K11253]
504939  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
504943  RXRB; retinoic acid receptor RXR-beta [KO:K08525]
505025  ID2; DNA-binding protein inhibitor ID-2 [KO:K17693]
505304  TLX1; T-cell leukemia homeobox protein 1 [KO:K09340]
505326  [KO:K01353] [EC:3.4.21.79]
505463  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
505691  CDKN2C; cyclin-dependent kinase 4 inhibitor C [KO:K06622]
505766  BMP2K; BMP-2-inducible protein kinase [KO:K08854] [EC:2.7.11.1]
505908  PDGFA; platelet-derived growth factor subunit A precursor [KO:K04359]
506270  PTK2; PTK2 protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]
506618  FOXO1; forkhead box protein O1 [KO:K07201]
506967  ATF1; cyclic AMP-dependent transcription factor ATF-1 [KO:K09053]
507100  SPI1; transcription factor PU.1 [KO:K09438]
507189  PRCC; proline-rich protein PRCC [KO:K13105]
507554  RXRA; retinoic acid receptor RXR-alpha [KO:K08524]
507663  NCOR1; nuclear receptor corepressor 1 [KO:K04650]
508233  RELA; transcription factor p65 [KO:K04735]
508330  KMT2A; histone-lysine N-methyltransferase 2A isoform X1 [KO:K09186] [EC:2.1.1.354]
508646  [KO:K01353] [EC:3.4.21.79]
508858  [KO:K01353] [EC:3.4.21.79]
509135  REL; proto-oncogene c-Rel [KO:K09254]
509418  CSF1R; macrophage colony-stimulating factor 1 receptor precursor [KO:K05090] [EC:2.7.10.1]
509500  RXRG; retinoic acid receptor RXR-gamma [KO:K08526]
509513  [KO:K10785]
510185  [KO:K05069]
510442  DOT1L; histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X7 [KO:K11427] [EC:2.1.1.360]
510459  HOXA9; homeobox protein Hox-A9 [KO:K21950]
510666  BMI1; polycomb complex protein BMI-1 [KO:K11459]
511037  TMPRSS2; transmembrane protease serine 2 [KO:K09633] [EC:3.4.21.122]
511077  MYC; myc proto-oncogene protein [KO:K04377]
511188  EYA1; eyes absent homolog 1 isoform X1 [KO:K15616] [EC:3.1.3.48]
511206  MPO; myeloperoxidase precursor [KO:K10789] [EC:1.11.2.2]
511371  SIX1; homeobox protein SIX1 [KO:K15614]
512237  PER2; period circadian protein homolog 2 [KO:K02633]
512254  MEF2C; myocyte-specific enhancer factor 2C [KO:K04454]
512259  HPGD; 15-hydroxyprostaglandin dehydrogenase [NAD(+)] [KO:K00069] [EC:1.1.1.141]
512613  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
512700  FLT3; receptor-type tyrosine-protein kinase FLT3 isoform X1 [KO:K05092] [EC:2.7.10.1]
512741  H3-5; histone H3.3C [KO:K11253]
512915  ZBTB17; zinc finger and BTB domain-containing protein 17 isoform X1 [KO:K10500]
513497  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
513669  PTCRA; pre T-cell antigen receptor alpha precursor [KO:K06056]
514031  ITGB7; integrin beta-7 precursor [KO:K06590]
514090  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
514386  BIRC3; baculoviral IAP repeat-containing protein 3 [KO:K16060]
515310  DUSP6; dual specificity protein phosphatase 6 [KO:K21946] [EC:3.1.3.16 3.1.3.48]
515670  ASPSCR1; tether containing UBX domain for GLUT4 [KO:K15627]
515700  IL1R2; interleukin-1 receptor type 2 precursor [KO:K04387]
516742  H4C14; H4 clustered histone 14 [KO:K11253]
517139  H3C1; histone H3.1 [KO:K11253]
518318  H3-4; histone H3.1t [KO:K11253]
518504  SIN3A; paired amphipathic helix protein Sin3a [KO:K11644]
518961  H4C19; H4 clustered histone 19 [KO:K11253]
519357  DDB2; DNA damage-binding protein 2 [KO:K10140]
520580  CDK9; cyclin-dependent kinase 9 [KO:K02211] [EC:2.7.11.22 2.7.11.23]
520800  TFE3; transcription factor E3 [KO:K09105]
521089  CCNT2; cyclin-T2 [KO:K15188]
521939  CCNA1; cyclin-A1 [KO:K06627]
521962  MLLT3; protein AF-9 [KO:K15187]
524303  SLC45A3; solute carrier family 45 member 3 [KO:K15379]
524810  [KO:K06856]
524933  FEV; protein FEV [KO:K09437]
526104  SIX4; homeobox protein SIX4 isoform X1 [KO:K15615]
526472  LDB1; LOW QUALITY PROTEIN: LIM domain-binding protein 1 [KO:K15617]
526824  ATM; serine-protein kinase ATM [KO:K04728] [EC:2.7.11.1]
528329  H4C13; H4 clustered histone 13 [KO:K11253]
528877  NR4A3; nuclear receptor subfamily 4 group A member 3 isoform X3 [KO:K08559]
529124  FLI1; Friend leukemia integration 1 transcription factor [KO:K09436]
529631  RUNX1; runt-related transcription factor 1 [KO:K08367]
530358  KLF3; Krueppel-like factor 3 [KO:K15605]
530616  TCF3; transcription factor E2-alpha [KO:K09063]
531990  HIST2H3D; histone H3 [KO:K11253]
533129  ETV4; ETS translocation variant 4 isoform X3 [KO:K15592]
533379  MLF1; myeloid leukemia factor 1 [KO:K15622]
533445  ARNT2; aryl hydrocarbon receptor nuclear translocator 2 [KO:K15589]
533700  DDX5; probable ATP-dependent RNA helicase DDX5 [KO:K12823] [EC:5.6.2.7]
534040  SPINT1; kunitz-type protease inhibitor 1 precursor [KO:K15619]
534073  EWSR1; RNA-binding protein EWS [KO:K13209]
534280  RARA; retinoic acid receptor alpha [KO:K08527]
534346  CEBPE; CCAAT/enhancer-binding protein epsilon [KO:K10051]
534401  ZBTB16; zinc finger and BTB domain-containing protein 16 [KO:K10055]
534626  GRIA3; glutamate receptor 3 precursor [KO:K05199]
534661  PAX8; paired box protein Pax-8 isoform X2 [KO:K09293]
535183  ZEB1; zinc finger E-box-binding homeobox 1 [KO:K09299]
535231  ERG; transcriptional regulator ERG [KO:K09435]
535376  TGFBR2; TGF-beta receptor type-2 precursor [KO:K04388] [EC:2.7.11.30]
536067  TAF15; TATA-binding protein-associated factor 2N [KO:K14651]
536229  [KO:K09381]
536911  RUNX2; runt-related transcription factor 2 isoform X6 [KO:K09278]
538371  PAX5; paired box protein Pax-5 isoform X1 [KO:K09383]
538627  WNT16; protein Wnt-16 precursor [KO:K01558]
538628  RUNX1T1; protein CBFA2T1 [KO:K10053]
539020  BCL6; B-cell lymphoma 6 protein [KO:K15618]
539222  PBX3; pre-B-cell leukemia transcription factor 3 [KO:K15610]
539314  BIRC2; baculoviral IAP repeat-containing protein 2 isoform X2 [KO:K16060]
539431  MEN1; menin [KO:K14970]
539542  HHEX; hematopoietically-expressed homeobox protein HHEX [KO:K08024]
539855  H3-3D; histone H3.3C-like [KO:K11253]
540309  ELK4; ETS domain-containing protein Elk-4 [KO:K04376]
540378  MDM2; E3 ubiquitin-protein ligase Mdm2 [KO:K06643] [EC:2.3.2.27]
540488  SMAD1; mothers against decapentaplegic homolog 1 [KO:K04676]
540616  MAX; protein max [KO:K04453]
540688  PBX1; pre-B-cell leukemia transcription factor 1 [KO:K09355]
540741  SP1; transcription factor Sp1 [KO:K04684]
540769  NSD2; histone-lysine N-methyltransferase NSD2 isoform X1 [KO:K11424] [EC:2.1.1.357]
540846  ETV1; ETS translocation variant 1 [KO:K09431]
540944  TRAF1; TNF receptor-associated factor 1 [KO:K03172]
540947  SS18; protein SSXT [KO:K15623]
540951  PAX3; paired box protein Pax-3 [KO:K09381]
541166  ETV5; ETS translocation variant 5 [KO:K15593]
541218  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
613345  [KO:K11253]
613877  MEIS1; homeobox protein Meis1 [KO:K15613]
614673  NUPR1; nuclear protein 1 [KO:K15626]
614876  LMO2; rhombotin-2 [KO:K15612]
615414  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
615458  LYL1; protein lyl-1 [KO:K15604]
615596  TSPAN7; tetraspanin-7 [KO:K06571]
616115  NFKB1; nuclear factor NF-kappa-B p105 subunit [KO:K02580]
616800  H3C12; histone H3.1 [KO:K11253]
616819  H3C10; histone H3.1 [KO:K11253]
616888  MYCN; N-myc proto-oncogene protein [KO:K09109]
617051  H3F3B; histone H3.3 [KO:K11253]
618054  PROM1; prominin-1 precursor [KO:K06532]
618133  SUPT3H; transcription initiation protein SPT3 homolog [KO:K11313]
618405  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
618473  TLX3; T-cell leukemia homeobox protein 3 [KO:K15607]
768207  SS18L1; calcium-responsive transactivator [KO:K15623]
777788  DDIT3; DNA damage-inducible transcript 3 protein [KO:K04452]
781067  JMJD1C; probable JmjC domain-containing histone demethylation protein 2C [KO:K11449] [EC:1.14.11.-]
781149  AFF1; AF4/FMR2 family member 1 [KO:K15184]
781224  [KO:K11253]
782183  WT1; Wilms tumor protein isoform X1 [KO:K09234]
782481  MAF; transcription factor Maf [KO:K09035]
783269  BCL11B; B-cell lymphoma/leukemia 11B isoform X1 [KO:K22046]
784386  HOXA10; homeobox protein Hox-A10 [KO:K17443]
784403  CDK14; cyclin-dependent kinase 14 [KO:K08821] [EC:2.7.11.22]
786126  [KO:K01353] [EC:3.4.21.79]
788077  H3C14; histone H3 [KO:K11253]
788250  H3C2; histone H3.1 [KO:K11253]
Reference
  Authors
Alcalay M, Orleth A, Sebastiani C, Meani N, Chiaradonna F, Casciari C, Sciurpi MT, Gelmetti V, Riganelli D, Minucci S, Fagioli M, Pelicci PG
  Title
Common themes in the pathogenesis of acute myeloid leukemia.
  Journal
Oncogene 20:5680-94 (2001)
DOI:10.1038/sj.onc.1204642
Reference
  Authors
Scandura JM, Boccuni P, Cammenga J, Nimer SD
  Title
Transcription factor fusions in acute leukemia: variations on a theme.
  Journal
Oncogene 21:3422-44 (2002)
DOI:10.1038/sj.onc.1205315
Reference
  Authors
Roumier C, Fenaux P, Lafage M, Imbert M, Eclache V, Preudhomme C
  Title
New mechanisms of AML1 gene alteration in hematological malignancies.
  Journal
Leukemia 17:9-16 (2003)
DOI:10.1038/sj.leu.2402766
Reference
  Authors
Lutterbach B, Hiebert SW
  Title
Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation.
  Journal
Gene 245:223-35 (2000)
DOI:10.1016/S0378-1119(00)00014-7
Reference
  Authors
Koschmieder S, Halmos B, Levantini E, Tenen DG
  Title
Dysregulation of the C/EBPalpha differentiation pathway in human cancer.
  Journal
J Clin Oncol 27:619-28 (2009)
DOI:10.1200/JCO.2008.17.9812
Reference
  Authors
Johansen LM, Iwama A, Lodie TA, Sasaki K, Felsher DW, Golub TR, Tenen DG
  Title
c-Myc is a critical target for c/EBPalpha in granulopoiesis.
  Journal
Mol Cell Biol 21:3789-806 (2001)
DOI:10.1128/MCB.21.11.3789-3806.2001
Reference
  Authors
Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP
  Title
Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia.
  Journal
Blood 106:2827-36 (2005)
DOI:10.1182/blood-2005-01-0358
Reference
  Authors
Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG, Hiddemann W, Behre G
  Title
The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
  Journal
Blood 101:270-7 (2003)
DOI:10.1182/blood-2002-04-1288
Reference
  Authors
Mueller BU, Pabst T, Osato M, Asou N, Johansen LM, Minden MD, Behre G, Hiddemann W, Ito Y, Tenen DG
  Title
Heterozygous PU.1 mutations are associated with acute myeloid leukemia.
  Journal
Blood 100:998-1007 (2002)
DOI:10.1182/blood.V100.3.998
Reference
  Authors
Jing Y
  Title
The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.
  Journal
Leuk Lymphoma 45:639-48 (2004)
DOI:10.1080/10428190310001609933
Reference
  Authors
Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, Sargin B, Kohler G, Stelljes M, Puccetti E, Ruthardt M, deVos S, Hiebert SW, Koeffler HP, Berdel WE, Serve H
  Title
Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.
  Journal
Mol Cell Biol 24:2890-904 (2004)
DOI:10.1128/MCB.24.7.2890-2904.2004
Reference
  Authors
Rice KL, Hormaeche I, Doulatov S, Flatow JM, Grimwade D, Mills KI, Leiva M, Ablain J, Ambardekar C, McConnell MJ, Dick JE, Licht JD
  Title
Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.
  Journal
Blood 114:5499-511 (2009)
DOI:10.1182/blood-2009-03-206524
Reference
  Authors
McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C
  Title
Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia.
  Journal
Proc Natl Acad Sci U S A 96:11464-9 (1999)
DOI:10.1073/pnas.96.20.11464
Reference
  Authors
Zelent A, Greaves M, Enver T
  Title
Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia.
  Journal
Oncogene 23:4275-83 (2004)
DOI:10.1038/sj.onc.1207672
Reference
  Authors
Sawinska M, Ladon D
  Title
Mechanism, detection and clinical significance of the reciprocal translocation t(12;21)(p12;q22) in the children suffering from acute lymphoblastic leukaemia.
  Journal
Leuk Res 28:35-42 (2004)
DOI:10.1016/S0145-2126(03)00160-7
Reference
  Authors
Guenther MG, Lawton LN, Rozovskaia T, Frampton GM, Levine SS, Volkert TL, Croce CM, Nakamura T, Canaani E, Young RA
  Title
Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia.
  Journal
Genes Dev 22:3403-8 (2008)
DOI:10.1101/gad.1741408
Reference
  Authors
Xia ZB, Popovic R, Chen J, Theisler C, Stuart T, Santillan DA, Erfurth F, Diaz MO, Zeleznik-Le NJ
  Title
The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression.
  Journal
Proc Natl Acad Sci U S A 102:14028-33 (2005)
DOI:10.1073/pnas.0506464102
Reference
  Authors
Wang QF, Wu G, Mi S, He F, Wu J, Dong J, Luo RT, Mattison R, Kaberlein JJ, Prabhakar S, Ji H, Thirman MJ
  Title
MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome.
  Journal
Blood 117:6895-905 (2011)
DOI:10.1182/blood-2010-12-324699
Reference
  Authors
Zeisig BB, Milne T, Garcia-Cuellar MP, Schreiner S, Martin ME, Fuchs U, Borkhardt A, Chanda SK, Walker J, Soden R, Hess JL, Slany RK
  Title
Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.
  Journal
Mol Cell Biol 24:617-28 (2004)
DOI:10.1128/MCB.24.2.617-628.2004
Reference
  Authors
Riz I, Hawley TS, Johnston H, Hawley RG
  Title
Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis.
  Journal
Br J Haematol 145:140-3 (2009)
DOI:10.1111/j.1365-2141.2008.07556.x
Reference
  Authors
Barth TF, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G, Parwaresch RM, Lichter P, Siebert R, Mooller P
  Title
Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.
  Journal
Blood 101:3681-6 (2003)
DOI:10.1182/blood-2002-08-2577
Reference
  Authors
Hinz M, Loser P, Mathas S, Krappmann D, Dorken B, Scheidereit C
  Title
Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.
  Journal
Blood 97:2798-807 (2001)
DOI:10.1182/blood.V97.9.2798
Reference
  Authors
Zuzel M, Cawley JC.
  Title
The biology of hairy cells.
  Journal
Best Pract Res Clin Haematol 16:1-13 (2003)
DOI:10.1016/S1521-6926(02)00082-8
Reference
  Authors
Hurt EM, Wiestner A, Rosenwald A, Shaffer AL, Campo E, Grogan T, Bergsagel PL, Kuehl WM, Staudt LM
  Title
Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma.
  Journal
Cancer Cell 5:191-9 (2004)
DOI:10.1016/S1535-6108(04)00019-4
Reference
  Authors
Martinez-Garcia E, Popovic R, Min DJ, Sweet SM, Thomas PM, Zamdborg L, Heffner A, Will C, Lamy L, Staudt LM, Levens DL, Kelleher NL, Licht JD
  Title
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.
  Journal
Blood 117:211-20 (2011)
DOI:10.1182/blood-2010-07-298349
Reference
  Authors
Brito JL, Walker B, Jenner M, Dickens NJ, Brown NJ, Ross FM, Avramidou A, Irving JA, Gonzalez D, Davies FE, Morgan GJ
  Title
MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells.
  Journal
Haematologica 94:78-86 (2009)
DOI:10.3324/haematol.13426
Reference
  Authors
Iida S, Rao PH, Ueda R, Chaganti RS, Dalla-Favera R
  Title
Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).
  Journal
Leuk Lymphoma 34:25-33 (1999)
DOI:10.3109/10428199909083377
Reference
  Authors
Ohno H, Ueda C, Akasaka T
  Title
The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
  Journal
Leuk Lymphoma 36:435-45 (2000)
DOI:10.3109/10428190009148390
Reference
  Authors
Prensner JR, Chinnaiyan AM
  Title
Oncogenic gene fusions in epithelial carcinomas.
  Journal
Curr Opin Genet Dev 19:82-91 (2009)
DOI:10.1016/j.gde.2008.11.008
Reference
  Authors
Brenner JC, Chinnaiyan AM
  Title
Translocations in epithelial cancers.
  Journal
Biochim Biophys Acta 1796:201-15 (2009)
DOI:10.1016/j.bbcan.2009.04.005
Reference
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
  Authors
Medendorp K, van Groningen JJ, Vreede L, Hetterschijt L, Brugmans L, van den Hurk WH, van Kessel AG
  Title
The renal cell carcinoma-associated oncogenic fusion protein PRCCTFE3 provokes p21 WAF1/CIP1-mediated cell cycle delay.
  Journal
Exp Cell Res 315:2399-409 (2009)
DOI:10.1016/j.yexcr.2009.04.022
Reference
  Authors
Kumar-Sinha C, Tomlins SA, Chinnaiyan AM
  Title
Recurrent gene fusions in prostate cancer.
  Journal
Nat Rev Cancer 8:497-511 (2008)
DOI:10.1038/nrc2402
Reference
  Authors
Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, Gong Y, Cheng H, Laxman B, Vellaichamy A, Shankar S, Li Y, Dhanasekaran SM, Morey R, Barrette T, Lonigro RJ, Tomlins SA, Varambally S, Qin ZS, Chinnaiyan AM
  Title
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.
  Journal
Cancer Cell 17:443-54 (2010)
DOI:10.1016/j.ccr.2010.03.018
Reference
  Authors
Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R, Cohen Y, Jacob-Hirsch J, Ehrlich M, Ben-Sasson S, Goldfinger N, Loewenthal R, Gazit E, Rotter V, Berger R
  Title
TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.
  Journal
PLoS One 6:e21650 (2011)
DOI:10.1371/journal.pone.0021650
Reference
  Authors
Cai C, Hsieh CL, Omwancha J, Zheng Z, Chen SY, Baert JL, Shemshedini L
  Title
ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.
  Journal
Mol Endocrinol 21:1835-46 (2007)
DOI:10.1210/me.2006-0480
Reference
  Authors
Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, Cao X, Singla N, Montie JE, Varambally S, Mehra R, Chinnaiyan AM
  Title
Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.
  Journal
Cancer Res 68:73-80 (2008)
DOI:10.1158/0008-5472.CAN-07-5352
Reference
  Authors
Westermark UK, Wilhelm M, Frenzel A, Henriksson MA
  Title
The MYCN oncogene and differentiation in neuroblastoma.
  Journal
Semin Cancer Biol 21:256-66 (2011)
DOI:10.1016/j.semcancer.2011.08.001
Reference
  Authors
Bell E, Chen L, Liu T, Marshall GM, Lunec J, Tweddle DA
  Title
MYCN oncoprotein targets and their therapeutic potential.
  Journal
Cancer Lett 293:144-57 (2010)
DOI:10.1016/j.canlet.2010.01.015
Reference
  Authors
Slack A, Chen Z, Tonelli R, Pule M, Hunt L, Pession A, Shohet JM
  Title
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
  Journal
Proc Natl Acad Sci U S A 102:731-6 (2005)
DOI:10.1073/pnas.0405495102
Reference
  Authors
Ochiai H, Takenobu H, Nakagawa A, Yamaguchi Y, Kimura M, Ohira M, Okimoto Y, Fujimura Y, Koseki H, Kohno Y, Nakagawara A, Kamijo T
  Title
Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.
  Journal
Oncogene 29:2681-90 (2010)
DOI:10.1038/onc.2010.22
Reference
  Authors
Chen L, Iraci N, Gherardi S, Gamble LD, Wood KM, Perini G, Lunec J, Tweddle DA
  Title
p53 is a direct transcriptional target of MYCN in neuroblastoma.
  Journal
Cancer Res 70:1377-88 (2010)
DOI:10.1158/0008-5472.CAN-09-2598
Reference
  Authors
Beierle EA, Trujillo A, Nagaram A, Kurenova EV, Finch R, Ma X, Vella J, Cance WG, Golubovskaya VM
  Title
N-MYC regulates focal adhesion kinase expression in human neuroblastoma.
  Journal
J Biol Chem 282:12503-16 (2007)
DOI:10.1074/jbc.M701450200
Reference
  Authors
Iraci N, Diolaiti D, Papa A, Porro A, Valli E, Gherardi S, Herold S, Eilers M, Bernardoni R, Della Valle G, Perini G
  Title
A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF.
  Journal
Cancer Res 71:404-12 (2011)
DOI:10.1158/0008-5472.CAN-10-2627
Reference
  Authors
Dreijerink KM, Hoppener JW, Timmers HM, Lips CJ
  Title
Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
  Journal
Nat Clin Pract Endocrinol Metab 2:562-70 (2006)
DOI:10.1038/ncpendmet0292
Reference
  Authors
Wu X, Hua X
  Title
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  Journal
Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702
Reference
  Authors
Sakurai A, Murakami A, Sano K, Uchino S, Fukushima Y
  Title
Unusual clinical and pathological presentation of a neuroendocrine tumor in a patient with multiple endocrine neoplasia type 1.
  Journal
Endocr J 56:887-95 (2009)
DOI:10.1507/endocrj.K09E-126
Reference
  Authors
Yang Y, Hua X
  Title
In search of tumor suppressing functions of menin.
  Journal
Mol Cell Endocrinol 265-266:34-41 (2007)
DOI:10.1016/j.mce.2006.12.032
Reference
  Authors
Aman P
  Title
Fusion oncogenes in tumor development.
  Journal
Semin Cancer Biol 15:236-43 (2005)
DOI:10.1016/j.semcancer.2005.01.009
Reference
  Authors
Fukuma M, Okita H, Hata J, Umezawa A
  Title
Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
  Journal
Oncogene 22:1-9 (2003)
DOI:10.1038/sj.onc.1206055
Reference
  Authors
Cironi L, Riggi N, Provero P, Wolf N, Suva ML, Suva D, Kindler V, Stamenkovic I
  Title
IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells.
  Journal
PLoS One 3:e2634 (2008)
DOI:10.1371/journal.pone.0002634
Reference
  Authors
Riggi N, Stamenkovic I.
  Title
The Biology of Ewing sarcoma.
  Journal
Cancer Lett 254:1-10 (2007)
DOI:10.1016/j.canlet.2006.12.009
Reference
  Authors
Jedlicka P
  Title
Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions.
  Journal
Int J Clin Exp Pathol 3:338-47 (2010)
Reference
  Authors
Ordonez JL, Osuna D, Herrero D, de Alava E, Madoz-Gurpide J
  Title
Advances in Ewing's sarcoma research: where are we now and what lies ahead?
  Journal
Cancer Res 69:7140-50 (2009)
DOI:10.1158/0008-5472.CAN-08-4041
Reference
  Authors
Jishage M, Fujino T, Yamazaki Y, Kuroda H, Nakamura T
  Title
Identification of target genes for EWS/ATF-1 chimeric transcription factor.
  Journal
Oncogene 22:41-9 (2003)
DOI:10.1038/sj.onc.1206074
Reference
  Authors
Gerald WL, Haber DA
  Title
The EWS-WT1 gene fusion in desmoplastic small round cell tumor.
  Journal
Semin Cancer Biol 15:197-205 (2005)
DOI:10.1016/j.semcancer.2005.01.005
Reference
  Authors
Filion C, Motoi T, Olshen AB, Lae M, Emnett RJ, Gutmann DH, Perry A, Ladanyi M, Labelle Y
  Title
The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.
  Journal
J Pathol 217:83-93 (2009)
DOI:10.1002/path.2445
Reference
  Authors
Kim S, Lee HJ, Jun HJ, Kim J
  Title
The hTAF II 68-TEC fusion protein functions as a strong transcriptional activator.
  Journal
Int J Cancer 122:2446-53 (2008)
DOI:10.1002/ijc.23379
Reference
  Authors
Sjogren H, Meis-Kindblom J, Kindblom LG, Aman P, Stenman G
  Title
Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma.
  Journal
Cancer Res 59:5064-7 (1999)
Reference
  Authors
Goransson M, Elias E, Stahlberg A, Olofsson A, Andersson C, Aman P
  Title
Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP beta-mediated interleukin 6 expression.
  Journal
Int J Cancer 115:556-60 (2005)
DOI:10.1002/ijc.20893
Reference
  Authors
Goransson M, Andersson MK, Forni C, Stahlberg A, Andersson C, Olofsson A, Mantovani R, Aman P
  Title
The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.
  Journal
Oncogene 28:270-8 (2009)
DOI:10.1038/onc.2008.378
Reference
  Authors
Willems SM, Schrage YM, Bruijn IH, Szuhai K, Hogendoorn PC, Bovee JV
  Title
Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and casein kinase II inhibition as a potential treatment option.
  Journal
Mol Cancer 9:257 (2010)
DOI:10.1186/1476-4598-9-257
Reference
  Authors
Linardic CM
  Title
PAX3-FOXO1 fusion gene in rhabdomyosarcoma.
  Journal
Cancer Lett 270:10-8 (2008)
DOI:10.1016/j.canlet.2008.03.035
Reference
  Authors
Barber TD, Barber MC, Tomescu O, Barr FG, Ruben S, Friedman TB
  Title
Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma.
  Journal
Genomics 79:278-84 (2002)
DOI:10.1006/geno.2002.6703
Reference
  Authors
Ishida M, Miyamoto M, Naitoh S, Tatsuda D, Hasegawa T, Nemoto T, Yokozeki H, Nishioka K, Matsukage A, Ohki M, Ohta T
  Title
The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma.
  Journal
Mol Cell Biol 27:1348-55 (2007)
DOI:10.1128/MCB.00658-06
Reference
  Authors
Jun HJ, Lee J, Lim do H, Park JO, Ahn G, Seo SW, Sung KS, Lim do H, Yoo KH, Choi YL
  Title
Expression of MET in alveolar soft part sarcoma.
  Journal
Med Oncol 27:459-65 (2010)
DOI:10.1007/s12032-009-9234-8
Reference
  Authors
Rivlin N, Brosh R, Oren M, Rotter V
  Title
Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis.
  Journal
Genes Cancer 2:466-74 (2011)
DOI:10.1177/1947601911408889
Reference
  Authors
Suzuki K, Matsubara H
  Title
Recent advances in p53 research and cancer treatment.
  Journal
J Biomed Biotechnol 2011:978312 (2011)
DOI:10.1155/2011/978312
Related
pathway
bta04115  p53 signaling pathway
bta05211  Renal cell carcinoma
bta05215  Prostate cancer
bta05216  Thyroid cancer
bta05221  Acute myeloid leukemia
KO pathway
ko05202   

DBGET integrated database retrieval system